Circulating Factors and Insulin Resistance. II. The Action of the Novel Myo-Inositol Cyclic 1,2-Inositol Phosphate Phosphoglycan Insulin Antagonist from Human Plasma in Regulating Pyruvate Dehydrogenase Phosphatase

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 3, 1996, Pages 1051-1057

  Galasko, Gail T F ^a,b   Abe, Sumiko ^a   Lilley, Kevin ^a   Zhang, Chenggui ^a   Larner, Joseph ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b S Illinois Univ Sch of Dent Med   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPERGLYCEMIC AGENT; INOSITOL 1,2 CYCLIC PHOSPHATE; INOSITOL DERIVATIVE; INSULIN; PHOSPHOGLYCAN; PYRUVATE DEHYDROGENASE PHOSPHATASE; UNCLASSIFIED DRUG;

ARTICLE; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME INHIBITION; GLUCOSE OXIDATION; INSULIN RESISTANCE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BLOOD PHYSIOLOGY; CATTLE; HUMANS; INOSITOL PHOSPHATES; INSULIN ANTAGONISTS; INSULIN RESISTANCE; MAGNESIUM; MYOCARDIUM; POLYSACCHARIDES; PYRUVATE DEHYDROGENASE (LIPOAMIDE)-PHOSPHATASE; SPERMINE;

EID: 0029866009     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.81.3.8772575     Document Type: Article

References (28)

1. Galasko GTF, Bao Y, Broomfield SJ, Hooper NM, Turner AJ, Larner J. 1995 Circulating factors and insulin resistance. I. A novel myo-inositol 1,2-cyclic phosphate phosphoglycan insulin antagonist from human plasma is elevated in non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 80:2419-2429.
2. Bruzik KS, Hakeem AA, Tsai M-D. 1994 Are D-and L-chiro-phosphoinositols substrates of phosphatidyl inositol-specific phospholipase C. Biochemistry. 33:8367-8374.
3. Jungas RL. 1971 Hormonal regulation of pyruvate dehydrogenase. Metabolism. 20:43-53.
4. Linn TC, Pettit FH, Reed LJ. 1969 α-Keto acid dehydrogenase complexes. X. Regulation of the activity of the pyruvate dehydrogenase complex from beef kidney mitochondria by phosphorylation and dephosphorylation. Proc Natl Acad Sci USA. 62:234-241.
5. Sale GJ, Randle PJ. 1982 Role of individual phosphorylation sites in inactivation of pyruvate dehydrogenase complex in rat heart mitochondria. Biochem J. 203:99-108.
6. Siess EA, Wieland OH. 1972 Purification and characterization of pyruvate dehydrogenase phosphatase from pig-heart muscle. Eur J Biochem. 26:96-105.
7. Thomas AP, Denton RM. 1986 Use of toluene-permeabilized mitochondria to study the regulation of adipose tissue pyruvate dehydrogenase in situ. Further evidence that insulin acts through stimulation of pyruvate dehydrogenase phosphate phosphatase. Biochem J. 238:93-101.
8. Teague WM, Pettit FH, Wu T-L, Silberman SR, Reed LJ. 1982 Purification and properties of pyruvate dehydrogenase phosphatase from bovine heart and kidney. Biochemistry. 21:5585-5592.
9. Lawson JE, Niu X-D, Browning KS, Trong HL, Yan J, Reed LJ. 1993 Molecular cloning and expression of the catalytic subunit of bovine pyruvate dehydrogenase phosphatase and sequence similarity with protein phosphatase 2C. Biochemistry. 32:8987-8993.
10. Larner J, Huang LC, Schwartz CFW, Oswald AS, Shen T-Y, Kinter M, Tang G, Zeller K. 1988 Rat liver insulin mediator which stimulates pyruvate dehydrogenase phosphatase contains galactosamine and d-chiroinositol. Biochem Biophys Res Commun. 151:1416-1426.
11. Larner J, Huang LC, Suzuki S, Tang G, Zhang C, Schwartz CFW, Romero G, Luttrell L, Kennington AS. 1989 Insulin mediators and the control of pyruvate dehydrogenase complex. Ann NY Acad Sci. 573:297-305.
12. Denton RM, Midgley PJW, Rutter GA, Thomas AP, McCormack JG. 1989 Studies into the mechanism whereby insulin activates pyruvate dehydrogenase complex in adipose tissue. Ann NY Acad Sci. 573:285-296.
13. Huang LC, Fonteles MC, Houston DC, Zhang C, Larner J. 1993 Chiro-inositol deficiency and insulin resistance. III. Acute glycogenic and hypoglycemic effects of two inositol phosphoglycan insulin mediators in normal and streptozotocin-diabetic rats. Endocrinology. 132:652-657.
14. Thompson MP, Larner J, Kilpatrick D. 1984 Purification and partial characterization of a putative mediator of insulin action on cyclic AMP-dependent protein kinase. Mol Cell Biochem. 62:67-75.
15. Malchoff CD, Huang L, Gillespie N, et al. 1987 A putative mediator of insulin action which inhibits adenylate cyclase and adenosine 3',5-monophosphate dependent protein kinase; partial purification from rat liver: site and kinetic mechanism of action. Endocrinology. 120:1327-1337.
16. Nestler JE, Romero G, Huang LC, Zhang C, Larner J. 1991 Insulin mediators are the signal transduction system responsible for insulin's actions on human placental steroidogenesis. Endocrinology. 129:2951-2956.
17. Lilley K, Zhang C, Villar-Palasi C, Larner J, Huang L. 1992 Insulin mediator stimulation of pyruvate dehydrogenase phosphatases. Arch Biochem Biophys. 296:170-174.
18. Kiechle FL, Jarett L, Popp DA, Kotagal N. 1980 Isolation from rat adipocytes of a chemical mediator for insulin activation of pyruvate dehydrogenase. Diabetes. 29:852-855.
19. Thomas AP, Diggle TA, Denton RM. 1986 Sensitivity of pyruvate dehydrogenase phosphate phosphatase to magnesium ions. Similar effects of spermine and insulin. Biochem J. 238:83-91.
20. Macauley SL, Jarett, L. 1985 Insulin mediator causes dephosphorylation of the a subunit of pyruvate dehydrogenase by stimulating phosphatase activity. Arch Biochem Biophys. 237:142-150.
21. Abe S, Huang LC, Larner J. 1995 Dephosphorylation of PDH by phosphoprotein phosphatases and its allosteric regulation by inositol glycans α-keto acid dehydrogenase complexes. In: Patel MS, Roche TE, Harris RA, eds. Berhauser Verlag; in press.
22. Kennington AS, Hill CR, Craig J, et al. 1990 Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitus. N Eng J Med. 323:373-378.
23. Craig JW, Lamer J, Asplin CM. 1994 Chiroinositol deficiency and insulin resistance: a clinical perspective. In: Draznin B, LeRoith D, eds. Molecular biology of diabetes. Totawa, NJ: Humana Press; vol 2:343-362.
24. Asplin I, Galasko G, Larner J. 1993 Chiro-inositol deficiency and insulin resistance: a comparison of the chiro-inositol and myo-inositol containing insulin mediators isolated from urine, hemodialysate and muscle of control and type II diabetic subjects. Proc Natl Acad Sci USA. 90:5924-5928.
25. Suzuki S, Kawasaki H, Satoh Y, et al. 1994 Urinary chiro-inositol excretion is an index marker of insulin sensitivity in Japanese type II diabetes. Diabetes Care. 17:1465-1468.
26. Ortmeyer HK, Bodkin NL, Lilley K, Larner J, Hansen BC. 1993 Chiroinositol deficiency and insulin resistance. I. Urinary excretion rate of chiroinositol is directly associated with insulin resistance in spontaneously diabetic rhesus monkeys. Endocrinology. 132:640-645.
27. Suzuki S, Taneda Y, Hirai S, et al. 1991 Molecular mechanism of insulin resistance in spontaneous diabetic G/K (Goto-Kakizaki) rats. In: Sakamoto N, Angel A, Hotta N, eds. New directions in research and clinical works for obesity and diabetes mellitus. Amsterdam: Elsevier; 197-203.
28. Farese RV, Standaert ML, Yamada K, et al. 1994 Insulin-induced activation of glycerol-3-phosphate acyltransferase by a chiro-inositol-containing insulin mediator is defective in adipocytes of insulin-resistant type II diabetic Goto-Kakizaki rats. Proc Natl Acad Sci USA. 91:11040-11044.